Corticosteroids and central serous chorioretinopathy. - Test2 - elhamkhani - TriplyDB

Corticosteroids and central serous chorioretinopathy.

Corticosteroids and central serous chorioretinopathy.

http://www.wikidata.org/entity/Q34152708

about

Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.Central serous chorioretinopathy after epidural steroid injection.Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy [Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab].Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy Helicobacter pylori infection and eye diseases: a systematic review.The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.Central serous chorioretinopathy: update on pathophysiology and treatment.Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy Therapeutic benefit of melatonin in refractory central serous chorioretinopathy A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy.Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy Systemic factors associated with central serous chorioretinopathy in Koreans.Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Indocyanine green angiography in chronic central serous chorioretinopathy Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy.Central serous chorioretinopathy in primary hyperaldosteronism Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing's Syndrome.En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy Bilateral choroidopathy in systemic lupus erythematosus.Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.Central serous chorioretinopathy, corticosteroids, and uveitis.Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers.Is myopia a protective factor against central serous chorioretinopathy?Adrenocortical adenoma and central serous chorioretinopathy: a rare association?Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study.Systemic complement activation in central serous chorioretinopathy.Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.

P2860

Q26752297-66BB30E6-08CF-4342-A131-AEB81E1D6E2C Q26824756-E95E2DAB-D0BD-4BC8-B959-76A83A787C16 Q31040895-47DADFE0-31DE-4390-B86F-25B03F5DA7E9 Q33195722-D781CCB4-2153-43F2-8A85-7EDF4DDE817E Q33224643-28D5A239-8B51-4AA2-A96B-C111DCD72AAC Q33904800-BF327ABA-D597-42B8-BFCD-82827960D6FA Q34423329-D9F927CD-C957-4F14-94D1-956DA9808861 Q34434358-ACCE916F-9DE8-4D05-AA1A-E3B4AB6BF350 Q34439977-2F4E6702-995A-4C88-98D2-28B318FE4AB9 Q34447890-FF1753D3-41E9-450C-BBFF-72E12879EA41 Q34454857-4429BF37-D22A-4AE7-8DD7-D8A29F8CAFB7 Q34493875-7A2352FB-7244-4DDA-B16C-E504EF14D37A Q34575021-1E26CF60-D176-43CE-A57B-6E47062CEBF2 Q34587658-5A730B61-4E7A-4EBF-9004-D8743B30ED2B Q34796150-7F5902B6-BF99-47A6-9759-CCF5CDB88FCF Q35586548-13486C31-2D83-45DD-878A-080C50E8CD76 Q35970032-00864A59-E199-4B33-8FA4-B7B7679CCE3E Q35980505-387416E9-E38A-430B-86BE-7EFC17B26DB5 Q36068308-33C79B80-671F-45DD-8194-C5F83AA79242 Q36128218-F4C65910-351D-468A-8E7A-1B4D5419BDA2 Q36342988-D1C65E35-EBE2-4E2C-847D-2CBC5A4CAAEB Q36407625-113E2370-8B9D-44BE-912B-7007E26FE5AA Q36576875-6DED042A-B287-4199-8F28-BCF285772B88 Q36685428-516F59F4-4058-42F5-9FE9-802676360D03 Q37169814-E92596C3-14E4-422A-B74E-B5A6B03A7B20 Q37233266-500C40C5-2742-4063-B952-9CECE0FC4C57 Q37302044-124C24BE-1550-423A-B5B0-B80FFBAA078B Q37486699-21E712DA-A838-4ADF-8AB8-48624448750C Q37619588-9AC87396-E407-4F22-A0D3-BD5807601485 Q37867847-A7A9F9CC-5985-4B91-BBFA-9FFD25156CF9 Q37949217-F9B6CDFD-552D-4331-B66B-4F72A584C0B3 Q37992703-EB9A6D8C-F556-405D-A61F-1EF29250F4C9 Q38025702-2F590996-0E50-46EA-8B44-0D0079BB65E0 Q38180640-47DEAF61-1D70-46D2-ADB8-7054F717EE45 Q38580269-91AF2F8E-3940-43D2-8B8A-3E6FB1B6F8B6 Q39256937-E0949B45-D8CE-4850-AB18-173CD286533D Q40290095-0D83D354-C632-4C89-9C68-90B5F52A5629 Q40974185-A017CF11-FA33-4EB6-8886-4D29E54E1CFF Q41106280-7A1091FA-0A26-4887-B95C-57B51FB0C1E8 Q41190093-27BF6721-63D8-4A1A-BEF3-92599854E8A5

P2860

Corticosteroids and central serous chorioretinopathy.

http://www.wikidata.org/entity/Q34152708

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Corticosteroids and central serous chorioretinopathy.

@ast

Corticosteroids and central serous chorioretinopathy.

@en

Corticosteroids and central serous chorioretinopathy.

@nl

type

label

Corticosteroids and central serous chorioretinopathy.

@ast

Corticosteroids and central serous chorioretinopathy.

@en

Corticosteroids and central serous chorioretinopathy.

@nl

prefLabel

Corticosteroids and central serous chorioretinopathy.

@ast

Corticosteroids and central serous chorioretinopathy.

@en

Corticosteroids and central serous chorioretinopathy.

@nl

P1433

Q34152708-89B6678B-29B2-426E-8FC2-921D63F97B41

P1476

Q34152708-6E1AC9F7-59ED-47B1-BBA7-994F0A7E1257

P2093

Q34152708-17D95A3D-4482-4E84-9D9D-30DF947B86BE

Q34152708-4985473E-1A98-4F79-AB6B-988D289AB913

Q34152708-50D00915-2C82-48AD-9803-ADD023806939

Q34152708-50FB059E-A6B9-481A-A68D-6C13EE6B7532

Q34152708-6C21E823-2805-43B1-9BC2-4FC9171CC105

Q34152708-7303021A-B36D-49F1-A578-4F2F9F3067CC

Q34152708-B23ECE89-2177-4B39-A65A-530F0729C4C0

P304

Q34152708-53970C5D-948B-4568-9B5E-2F327E4D7C0E

P31

Q34152708-DCDEB205-30AE-4CFE-A08F-582F92A790D5

P356

Q34152708-E76AEADD-5B6C-40C7-9263-0CD508CEA21D

P433

Q34152708-649998FD-654A-4BF5-B2EC-0805549D9127

P478

Q34152708-3CEC4DA3-5448-4F53-9CE6-38AC2FE97F63

P50

Q34152708-25D3DD0B-7C75-481E-8748-A3356386218C

P577

Q34152708-D58C6749-9444-4BC6-9C4A-B4CE1EE38CCD

P698

Q34152708-17017C94-6DA8-4D7D-8D54-4931346F10AA

P356

S0161-6420(02)01117-X

P1433

P1476

Corticosteroids and central serous chorioretinopathy.

@en

P2093

Cynthia A Carvalho-Recchia

http://www.w3.org/2001/XMLSchema#string

Hanna Rodriguez-Coleman

http://www.w3.org/2001/XMLSchema#string

K Bailey Freund

http://www.w3.org/2001/XMLSchema#string

Lawrence A Yannuzzi

http://www.w3.org/2001/XMLSchema#string

Marcio Lenharo

http://www.w3.org/2001/XMLSchema#string

Silvana Negrão

http://www.w3.org/2001/XMLSchema#string

Tomohiro Iida

http://www.w3.org/2001/XMLSchema#string

P304

1834-1837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0161-6420(02)01117-X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Richard F Spaide

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12359603

http://www.w3.org/2001/XMLSchema#string